-
PurposePlasmid containing the SF3B3-miniXon/Firefly luciferase cassette. Translation of Firefly luciferase is controlled by splicing modulation of the SF3B3-miniXon by LMI070.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 174660 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGL4.10[luc2]
-
Backbone manufacturerPromega
- Backbone size w/o insert (bp) 4242
- Total vector size (bp) 5261
-
Modifications to backboneRemoved BamHI site in backbone plasmid
-
Vector typeMammalian Expression, Luciferase
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameminiXon cassette
-
SpeciesH. sapiens (human)
-
Insert Size (bp)595
-
MutationKozak ATG initiation sequence in middle exon
- Promoter RSV
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site HindIII (not destroyed)
- 3′ cloning site BamhI (not destroyed)
- 5′ sequencing primer -
- 3′ sequencing primer TCCCGTCTTCGAGTGGGTA (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pGL4.10/RSV_SF3B3-miniXon_Luciferase was a gift from Beverly L. Davidson (Addgene plasmid # 174660 ; http://n2t.net/addgene:174660 ; RRID:Addgene_174660) -
For your References section:
Regulated control of gene therapies by drug-induced splicing. Monteys AM, Hundley AA, Ranum PT, Tecedor L, Muehlmatt A, Lim E, Lukashev D, Sivasankaran R, Davidson BL. Nature. 2021 Jul 28. pii: 10.1038/s41586-021-03770-2. doi: 10.1038/s41586-021-03770-2. 10.1038/s41586-021-03770-2 PubMed 34321659